Live Breaking News & Updates on Complement Inhibition

Stay updated with breaking news from Complement inhibition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Use of Povetacicept in Treatment of IgA Nephropathy

Drs Jonathan Barratt and Brad Rovin comment on clinical trial data regarding the use of povetacicept for the treatment of IgAN. ....

United States , Brad Rovin , Jonathan Barratt , American Society Of Nephrology , American Society , Complement Inhibition , B Cell Modulation , Blys April ,

Dual Inhibition of BlyS and APRIL in IgA Nephropathy

Nephrology experts explore the role of dual inhibition of BlyS and APRIL in the treatment of IgAN, and how this can impact disease pathogenesis. ....

Jonathan Barratt , Brad Rovin , Complement Inhibition , B Cell Modulation , Blys April Targeting ,

New Therapies in IgA Nephropathy

Brad Rovin, MD, outlines the use of complement inhibitors as an alternative to systemic glucocorticoids for the treatment of IgAN. ....

Brad Rovin , Jonathan Barratt , Complement Inhibition , B Cell Modulation , Blys April Targeting ,

Complement therapy in transplant patients in C3G

Anuja Java, MD, discusses the role of complement inhibitors in transplant patients with C3G. ....

Jonathan Barratt , Kidney Transplant , Complement Inhibition , C3 Inhibitor ,